Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Neurochem Res
2014 Jun 01;396:1057-1067. doi: 10.1007/s11064-013-1156-3.
Show Gene links
Show Anatomy links
Unexpected Properties of δ-Containing GABAA Receptors in Response to Ligands Interacting with the α+ β- Site.
Mirheydari P, Ramerstorfer J, Varagic Z, Scholze P, Wimmer L, Mihovilovic MM, Sieghart W, Ernst M.
???displayArticle.abstract??? GABAA receptors are the major inhibitory neurotransmitter receptors in the central nervous system and are the targets of many clinically important drugs, which modulate GABA induced chloride flux by interacting with separate and distinct allosteric binding sites. Recently, we described an allosteric modulation occurring upon binding of pyrazoloquinolinones to a novel binding site at the extracellular α+ β- interface. Here, we investigated the effect of 4-(8-methoxy-3-oxo-3,5-dihydro-2H-pyrazolo[4,3-c]quinolin-2-yl)benzonitrile (the pyrazoloquinolinone LAU 177) at several αβ, αβγ and αβδ receptor subtypes. LAU 177 enhanced GABA-induced currents at all receptors investigated, and the extent of modulation depended on the type of α and β subunits present within the receptors. Whereas the presence of a γ2 subunit within αβγ2 receptors did not dramatically change LAU 177 induced modulation of GABA currents compared to αβ receptors, we observed an unexpected threefold increase in modulatory efficacy of this compound at α1β2,3δ receptors. Steric hindrance experiments as well as inhibition by the functional α+ β- site antagonist LAU 157 indicated that the effects of LAU 177 at all receptors investigated were mediated via the α+ β- interface. The stronger enhancement of GABA-induced currents by LAU 177 at α1β3δ receptors was not observed at α4,6β3δ receptors. Other experiments indicated that this enhancement of modulatory efficacy at α1β3δ receptors was not observed with another α+ β- modulator, and that the efficacy of modulation by α+ β- ligands is influenced by all subunits present in the receptor complex and by structural details of the respective ligand.
???displayArticle.pubmedLink???
24072672 ???displayArticle.pmcLink???PMC3921099 ???displayArticle.link???Neurochem Res ???displayArticle.grants???[+]
W 1232-B11 Austrian Science Fund FWF, W 1232 Austrian Science Fund FWF, FWF_W 1232 Austrian Science Fund FWF
Barrera,
Atomic force microscopy reveals the stoichiometry and subunit arrangement of the alpha4beta3delta GABA(A) receptor.
2008, Pubmed
Barrera,
Atomic force microscopy reveals the stoichiometry and subunit arrangement of the alpha4beta3delta GABA(A) receptor.
2008,
Pubmed Baumann,
Subunit arrangement of gamma-aminobutyric acid type A receptors.
2001,
Pubmed
,
Xenbase Baur,
Molecular analysis of the site for 2-arachidonylglycerol (2-AG) on the β₂ subunit of GABA(A) receptors.
2013,
Pubmed
,
Xenbase Baur,
Diversity of structure and function of alpha1alpha6beta3delta GABAA receptors: comparison with alpha1beta3delta and alpha6beta3delta receptors.
2010,
Pubmed
,
Xenbase Belelli,
The interaction of the general anesthetic etomidate with the gamma-aminobutyric acid type A receptor is influenced by a single amino acid.
1997,
Pubmed
,
Xenbase Bollan,
The promiscuous role of the epsilon subunit in GABAA receptor biogenesis.
2008,
Pubmed
,
Xenbase Brickley,
Extrasynaptic GABA(A) receptors: their function in the CNS and implications for disease.
2012,
Pubmed Chiara,
Mapping general anesthetic binding site(s) in human α1β3 γ-aminobutyric acid type A receptors with [³H]TDBzl-etomidate, a photoreactive etomidate analogue.
2012,
Pubmed Chiara,
Specificity of intersubunit general anesthetic-binding sites in the transmembrane domain of the human α1β3γ2 γ-aminobutyric acid type A (GABAA) receptor.
2013,
Pubmed Ebert,
Extensive heterogeneity of recombinant gamma-aminobutyric acidA receptors expressed in alpha 4 beta 3 gamma 2-transfected human embryonic kidney 293 cells.
1996,
Pubmed Ernst,
Comparative modeling of GABA(A) receptors: limits, insights, future developments.
2003,
Pubmed Ernst,
Comparative models of GABAA receptor extracellular and transmembrane domains: important insights in pharmacology and function.
2005,
Pubmed Farrant,
Variations on an inhibitory theme: phasic and tonic activation of GABA(A) receptors.
2005,
Pubmed Farrar,
Stoichiometry of a ligand-gated ion channel determined by fluorescence energy transfer.
1999,
Pubmed Fryer,
Structure-activity relationship studies at the benzodiazepine receptor (BZR): a comparison of the substitutent effects of pyrazoloquinolinone analogs.
1993,
Pubmed Glykys,
A new naturally occurring GABA(A) receptor subunit partnership with high sensitivity to ethanol.
2007,
Pubmed Horton,
Gene splicing by overlap extension.
1993,
Pubmed Hosie,
Conserved site for neurosteroid modulation of GABA A receptors.
2009,
Pubmed Hosie,
Endogenous neurosteroids regulate GABAA receptors through two discrete transmembrane sites.
2006,
Pubmed Jenkins,
Evidence for a common binding cavity for three general anesthetics within the GABAA receptor.
2001,
Pubmed Jensen,
A study of subunit selectivity, mechanism and site of action of the delta selective compound 2 (DS2) at human recombinant and rodent native GABA(A) receptors.
2013,
Pubmed
,
Xenbase Kaur,
Unanticipated structural and functional properties of delta-subunit-containing GABAA receptors.
2009,
Pubmed
,
Xenbase Li,
Identification of a GABAA receptor anesthetic binding site at subunit interfaces by photolabeling with an etomidate analog.
2006,
Pubmed Mihic,
Sites of alcohol and volatile anaesthetic action on GABA(A) and glycine receptors.
1997,
Pubmed
,
Xenbase Nury,
X-ray structures of general anaesthetics bound to a pentameric ligand-gated ion channel.
2011,
Pubmed Nusser,
Segregation of different GABAA receptors to synaptic and extrasynaptic membranes of cerebellar granule cells.
1998,
Pubmed Olsen,
International Union of Pharmacology. LXX. Subtypes of gamma-aminobutyric acid(A) receptors: classification on the basis of subunit composition, pharmacology, and function. Update.
2008,
Pubmed Ramerstorfer,
The point mutation gamma 2F77I changes the potency and efficacy of benzodiazepine site ligands in different GABAA receptor subtypes.
2010,
Pubmed Ramerstorfer,
The GABAA receptor alpha+beta- interface: a novel target for subtype selective drugs.
2011,
Pubmed
,
Xenbase Shu,
Characteristics of concatemeric GABA(A) receptors containing α4/δ subunits expressed in Xenopus oocytes.
2012,
Pubmed
,
Xenbase Sieghart,
Structure and pharmacology of gamma-aminobutyric acidA receptor subtypes.
1995,
Pubmed Sigel,
The effect of subunit composition of rat brain GABAA receptors on channel function.
1990,
Pubmed
,
Xenbase Sigel,
Mapping of the benzodiazepine recognition site on GABA(A) receptors.
2002,
Pubmed Smith,
Functional domains of GABAA receptors.
1995,
Pubmed Spurny,
Multisite binding of a general anesthetic to the prokaryotic pentameric Erwinia chrysanthemi ligand-gated ion channel (ELIC).
2013,
Pubmed
,
Xenbase Spurny,
Pentameric ligand-gated ion channel ELIC is activated by GABA and modulated by benzodiazepines.
2012,
Pubmed
,
Xenbase Sun,
Distribution of alpha1, alpha4, gamma2, and delta subunits of GABAA receptors in hippocampal granule cells.
2004,
Pubmed Tretter,
Stoichiometry and assembly of a recombinant GABAA receptor subtype.
1997,
Pubmed Varagic,
Identification of novel positive allosteric modulators and null modulators at the GABAA receptor α+β- interface.
2013,
Pubmed
,
Xenbase Varagic,
Subtype selectivity of α+β- site ligands of GABAA receptors: identification of the first highly specific positive modulators at α6β2/3γ2 receptors.
2013,
Pubmed
,
Xenbase Yamakura,
Anesthetics and ion channels: molecular models and sites of action.
2001,
Pubmed Zheleznova,
alpha1beta2delta, a silent GABAA receptor: recruitment by tracazolate and neurosteroids.
2008,
Pubmed
,
Xenbase